Electric vehicles, crypto, and genomics excite many investors with their potential for innovation and big returns. But betting against those sectors with an exchange-traded fund has been the winning strategy this year. Stocks like
Tesla
Coinbase Global, and
Crispr Therapeutics
are all down sharply, fueling gains for the
AXS Short Innovation Daily
ETF, up 61%.
AXS didn’t pick those stocks out of a hat. They’re held by
ARK Innovation
(ticker: ARKK), the big thematic tech ETF run by Cathie Wood. The AXS Short Innovation ETF (SARK) is a mirror image of ARK Innovation—shorting the very stocks that Wood favors. This year, ARKK’s 62% losses have been SARK’s gains.